TScan Therapeutics Inc. is a biotechnology company focused on developing novel T-cell receptor (TCR) therapies to treat a wide range of diseases, including cancer. Their proprietary platform enables the identification of unique TCRs with the potential to effectively target tumors, offering new hope for patients and transforming the field of immunotherapy.
